<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05791006</url>
  </required_header>
  <id_info>
    <org_study_id>25C121</org_study_id>
    <nct_id>NCT05791006</nct_id>
  </id_info>
  <brief_title>Neuropsychology of Financial Capacity</brief_title>
  <acronym>NEUROFIN</acronym>
  <official_title>Neuropsychology of Financial Capacity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istituto Auxologico Italiano</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istituto Auxologico Italiano</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The present project aims to investigate the financial capacity in patients diagnosed with&#xD;
      Parkinson's Disease or parkinsonism, brain tumor (glioma or meningioma) and cerebrovascular&#xD;
      lesion (stroke), in order to evaluate the presence and degree of impairment, and the role of&#xD;
      some factors as potential predictors of financial incapacity.&#xD;
&#xD;
      The term 'financial capacity' means both operations relating, for example, to asset&#xD;
      management or investing money, and activities of daily life such as shopping or using small&#xD;
      sums of money; these activities are mediated by different cognitive functions, from numerical&#xD;
      and arithmetic skills to decision making. Financial capacity is, in fact, an instrumental&#xD;
      activity of daily life (i.e. Instrumental Activity Of Daily Living, I-ADL) whose impairment&#xD;
      negatively affects the functional autonomy of the individual, so as to be subject to legal&#xD;
      protection.&#xD;
&#xD;
      To assess financial capacity, the Numerical Activities of Daily Living - Financial (NADL-F;&#xD;
      Arcara et al., 2017) will be administered, a battery of tests aimed at investigating both&#xD;
      financial performance and financial competence according to the most recent&#xD;
      neuropsychological models proposed in the literature.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 4, 2021</start_date>
  <completion_date type="Anticipated">November 30, 2024</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Numerical Activity of Daily Living Financial (NADL-F) in Patients with Parkinson's Disease/Parkinsonisms</measure>
    <time_frame>At baseline</time_frame>
    <description>Assessment of financial capacity; score range=0-62; higher scores indicate higher financial capacities</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Numerical Activity of Daily Living Financial (NADL-F) in Patients with ischemic or haemorrhagic stroke</measure>
    <time_frame>At baseline</time_frame>
    <description>Assessment of financial capacity; score range=0-62; higher scores indicate higher financial capacities</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in Numerical Activity of Daily Living - Financial (NADL-F)Patients with brain tumors</measure>
    <time_frame>At 3 and 12 months follow up</time_frame>
    <description>Assessment of financial capacity; score range=0-62; higher scores indicate higher financial capacities</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Montreal Cognitive Assessment (MoCA)</measure>
    <time_frame>At baseline</time_frame>
    <description>Assessment of global cognitive functioning</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Frontal Assessment Battery (FAB)</measure>
    <time_frame>At baseline</time_frame>
    <description>Assessment of global cognitive functioning</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Activities of daily living questionnaire (ADL)</measure>
    <time_frame>At baseline</time_frame>
    <description>Assessment of function independence in everyday life</description>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">99</enrollment>
  <condition>Parkinson Disease</condition>
  <condition>Brain Tumor</condition>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>Patients with Parkinson's Disease/Parkinsonisms</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with brain tumors</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with ischemic or haemorrhagic stroke</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy Controls</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Neuropsychological tests</intervention_name>
    <description>Neuropsychological assessment with:&#xD;
NADL-F&#xD;
Frontal Assessment Battery (FAB)&#xD;
functional scales assessing activities of daily living (ADL) and instrumental activities of daily living (I-ADL)&#xD;
Mini-Mental Parkinson (MMP) - For Parkinson's Disease patients&#xD;
Montreal Cognitive Assessment (MoCA) - for brain tumor and stroke patients</description>
    <arm_group_label>Healthy Controls</arm_group_label>
    <arm_group_label>Patients with Parkinson's Disease/Parkinsonisms</arm_group_label>
    <arm_group_label>Patients with brain tumors</arm_group_label>
    <arm_group_label>Patients with ischemic or haemorrhagic stroke</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        -  Patients with Parkinson's Disease/parkinsonisms&#xD;
&#xD;
          -  Patients with brain tumor&#xD;
&#xD;
          -  Patients with stroke&#xD;
&#xD;
          -  Healthy controls&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age &gt; 18 years&#xD;
&#xD;
          -  Clinical diagnosis of interest for clinical groups&#xD;
&#xD;
          -  For stroke patients: disease duration &gt; 1 month&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Other brain disorders different from those of interest&#xD;
&#xD;
          -  Sensory-motor deficits that could prevent neuropsychological assessment&#xD;
&#xD;
          -  Language disorders that could prevent neuropsychological assessment&#xD;
&#xD;
          -  Global cognitive impairment as indexed by MoCA &lt; 26 or MMP &lt; 22.85&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Nadia Bolognini, PhD</last_name>
    <phone>+39025821</phone>
    <phone_ext>8132</phone_ext>
    <email>n.bolognini@auxologico.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Istituto Auxologico Italiano IRCCS</name>
      <address>
        <city>Milan</city>
        <state>Lombardia</state>
        <zip>20122</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nadia Bolognini, PhD</last_name>
      <phone>+39025821</phone>
      <phone_ext>8132</phone_ext>
      <email>n.bolognini@auxologico.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Arcara G, Burgio F, Benavides-Varela S, Toffano R, Gindri P, Tonini E, Meneghello F, Semenza C. Numerical Activities of Daily Living - Financial (NADL-F): A tool for the assessment of financial capacities double dagger. Neuropsychol Rehabil. 2019 Aug;29(7):1062-1084. doi: 10.1080/09602011.2017.1359188. Epub 2017 Sep 7.</citation>
    <PMID>28880732</PMID>
  </reference>
  <verification_date>March 2023</verification_date>
  <study_first_submitted>March 5, 2023</study_first_submitted>
  <study_first_submitted_qc>March 16, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">March 30, 2023</study_first_posted>
  <last_update_submitted>March 16, 2023</last_update_submitted>
  <last_update_submitted_qc>March 16, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">March 30, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

